Our Company | Diaceutics
  • Our Vision

    Better Testing. Better Treatment.
1
/
3
/

Who we are

Diaceutics is the diagnostic development and commercialization service provider.

What we do

We have been leading this field for 13 years, entirely focused on the intersection between diagnostics and therapeutic decision making. We provide an end to end service that encompasses everything from understanding the diagnostic landscape to test implementation in treatment pathways. This is all enabled by a robust flow of data from our global laboratory network.

What we stand for

Our ultimate goal is to drive better testing to enable better treatment decisions for patients.

Who we work with

lilly
source-bioscience
takeda
neo-genomics
bill-and-melinda-gates-foundation
promega
novartis
merck
bluebirdbio
roche
pfizer
boehringer-ingelheim
janssen
ganymed
celgene
astellas
amgen
synlab
bayer
lexicon
bristol-myers-squibb
abbvie
incyte
gsk
immunogen
astrazeneca
daiichi-sankyo

Our Vision

Partnering with stakeholders in healthcare globally to empower patients to receive better treatments through better testing.

Facebook
Twitter
YouTube
LinkedIn